The impasse over US drug reimportation may be a blessing in disguise
This article was originally published in SRA
Executive Summary
The growth of expenditures on prescription drugs in the US is prompting consumers and policy makers to explore alternative routes to control drug spending. Senior citizens and uninsured people have been among the hardest-hit populations during the latest economic recession in particular and consumers have been forced to live with difficult choices. Some 15-25% of the population has reported not filling a prescription on time and/or reducing a prescribed dosage due to lack of affordability1,2.